S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Log in

Pharma-Bio Serv Stock Forecast, Price & News

0.00 (0.00 %)
(As of 03/5/2021 12:00 AM ET)
Today's Range
Now: $1.47
50-Day Range
MA: $1.41
52-Week Range
Now: $1.47
Volume1,009 shs
Average Volume18,926 shs
Market Capitalization$34.45 million
P/E Ratio14.70
Dividend YieldN/A
Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm. It provides compliance consulting services to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products in Puerto Rico, the United States, Europe, and Brazil. The company's technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.


PBSV: Pharma-Bio Serv – Looking Ahead to 2021-2022
December 29, 2020 |  finance.yahoo.com
Pharma-Bio Serv Inc.
December 2, 2020 |  barrons.com
See More Headlines

Industry, Sector and Symbol

Industry Management consulting services
Current SymbolOTCMKTS:PBSV
Year FoundedN/A



Sales & Book Value

Annual Sales$19.51 million
Cash Flow$0.11 per share
Book Value$0.88 per share


Net Income$2.09 million


Market Cap$34.45 million
Next Earnings Date3/15/2021 (Estimated)
OptionableNot Optionable


Overall MarketRank

1.25 out of 5 stars

Business Services Sector

163rd out of 442 stocks

Management Consulting Services Industry

16th out of 46 stocks

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 3.1 5 -4 -3 -2 -1 -
0.00 (0.00 %)
(As of 03/5/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PBSV News and Ratings via Email

Sign-up to receive the latest news and ratings for PBSV and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Pharma-Bio Serv (OTCMKTS:PBSV) Frequently Asked Questions

What stocks does MarketBeat like better than Pharma-Bio Serv?

Wall Street analysts have given Pharma-Bio Serv a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Pharma-Bio Serv wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Pharma-Bio Serv's next earnings date?

Pharma-Bio Serv is scheduled to release its next quarterly earnings announcement on Monday, March 15th 2021.
View our earnings forecast for Pharma-Bio Serv

How were Pharma-Bio Serv's earnings last quarter?

Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) posted its quarterly earnings results on Monday, February, 1st. The company reported $0.01 earnings per share (EPS) for the quarter. The business earned $5.03 million during the quarter. Pharma-Bio Serv had a trailing twelve-month return on equity of 11.08% and a net margin of 11.16%.
View Pharma-Bio Serv's earnings history

How has Pharma-Bio Serv's stock price been impacted by Coronavirus (COVID-19)?

Pharma-Bio Serv's stock was trading at $0.85 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, PBSV shares have increased by 72.9% and is now trading at $1.47.
View which stocks have been most impacted by COVID-19

Who are Pharma-Bio Serv's key executives?

Pharma-Bio Serv's management team includes the following people:
  • Mr. Victor Sanchez, CEO, Pres & Pres of European Operations (Age 50, Pay $235.55k)
  • Ms. Elizabeth Plaza, Founder & Sr. Strategic Consultant (Age 57, Pay $539.67k)
  • Mr. Pedro J. Lasanta, CFO, VP of Fin. & Admin. and Sec. (Age 61, Pay $186.18k)
  • Ms. Nelida Plaza, Operations Pres (Age 53)
  • Ms. Miriam Marrero M.B.A., HR Mang.

Who are some of Pharma-Bio Serv's key competitors?

What other stocks do shareholders of Pharma-Bio Serv own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pharma-Bio Serv investors own include Zynerba Pharmaceuticals (ZYNE), Allena Pharmaceuticals (ALNA), AstroNova (ALOT), Oracle (ORCL), AT&T (T), Yintech Investment (YIN), Aeglea BioTherapeutics (AGLE), Ampliphi Biosciences (APHB), Carnival Co. & (CCL) and Earthstone Energy (ESTE).

What is Pharma-Bio Serv's stock symbol?

Pharma-Bio Serv trades on the OTCMKTS under the ticker symbol "PBSV."

How do I buy shares of Pharma-Bio Serv?

Shares of PBSV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Pharma-Bio Serv's stock price today?

One share of PBSV stock can currently be purchased for approximately $1.47.

How much money does Pharma-Bio Serv make?

Pharma-Bio Serv has a market capitalization of $34.45 million and generates $19.51 million in revenue each year. The company earns $2.09 million in net income (profit) each year or $0.09 on an earnings per share basis.

How many employees does Pharma-Bio Serv have?

Pharma-Bio Serv employs 220 workers across the globe.

What is Pharma-Bio Serv's official website?

The official website for Pharma-Bio Serv is www.pharmabioserv.com.

Where are Pharma-Bio Serv's headquarters?

Pharma-Bio Serv is headquartered at Pharma-Bio Serv Building Suite 6 Road 696, DORADO PR, 00646.

How can I contact Pharma-Bio Serv?

Pharma-Bio Serv's mailing address is Pharma-Bio Serv Building Suite 6 Road 696, DORADO PR, 00646. The company can be reached via phone at 787-278-2709 or via email at [email protected]

This page was last updated on 3/6/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.